I now have comprehensive information. Let me compile the complete, structured answer.
Anterior Abdominal Wall Tumor - FNAC: Fibroepithelial Neoplasm
Overview: Anterior Abdominal Wall Tumors
The anterior abdominal wall can harbour a wide spectrum of lesions - from benign to malignant, from primary to metastatic. FNAC (Fine Needle Aspiration Cytology) is the first-line diagnostic tool for characterising these masses quickly and non-invasively before definitive management.
Spectrum of abdominal wall masses on FNAC (70 cases study):
- Benign neoplasm: 52.9% (most common - lipoma)
- Non-neoplastic lesions: 30% (abscess, suture granuloma, endometriosis, hematoma)
- Malignant neoplasm: 17.1% (most common - metastatic adenocarcinoma)
Classification of Anterior Abdominal Wall Tumors
A. Non-neoplastic / Benign Inflammatory
| Lesion | Key Features |
|---|
| Suture granuloma | History of prior surgery; granulomatous reaction to suture material |
| Abscess / Infected wound | Fluctuant, tender, inflammatory signs |
| Hematoma | Post-trauma or post-surgery; ecchymosis |
| Epidermoid / sebaceous cyst | Superficial, punctum visible, cheesy contents |
| Keloid | At scar site, firm, raised |
| Endometriosis (scar) | In surgical scar (C-section site); cyclical pain/swelling with menstruation |
B. Primary Benign Neoplasms
| Tumor | Notes |
|---|
| Lipoma | Most common benign tumour - soft, lobulated, slips away on palpation |
| Fibroma / Desmoid fibromatosis | Firm, deep-seated; locally aggressive |
| Neurofibroma / Schwannoma | Neural sheath origin; may be multiple in NF1 |
| Fibroepithelial polyp (skin tag) | Soft, pedunculated, on skin surface |
| Nodular fasciitis | Reactive fibrous proliferation; rapidly growing; can mimic malignancy |
| Haemangioma / Vascular malformation | Soft, compressible; may increase with Valsalva |
C. Primary Malignant Neoplasms
| Tumor | Notes |
|---|
| Desmoid tumor (aggressive fibromatosis) | Locally aggressive; does not metastasize; most common primary abdominal wall "sarcoma-like" |
| Dermatofibrosarcoma protuberans (DFSP) | Low-grade dermal sarcoma; nodular; t(17;22) translocation |
| Liposarcoma | Deep-seated; large; heterogeneous on imaging |
| Leiomyosarcoma / Other sarcomas | Rare; aggressive |
| Melanoma | Superficial origin |
D. Metastatic Tumors (Most Common Malignant Cause)
- Sister Mary Joseph nodule - umbilical metastasis from intra-abdominal primary (gastric, colorectal, ovarian)
- Subcutaneous metastases from breast, colon, stomach, ovarian primaries
- Adenocarcinoma is the most common histotype on FNAC
FNAC of Anterior Abdominal Wall Tumors
Why FNAC?
- Simple, fast, minimally invasive
- Performed at bedside or under USS guidance
- Provides immediate triage: benign vs malignant vs inflammatory
- Can guide decision between conservative management, surgery, chemotherapy, or further biopsy
- Particularly important at the umbilicus - may reveal occult systemic malignancy
Technique
- Patient supine; mass identified clinically ± USS guidance
- 22-23G needle, 10 mL syringe
- 2-3 passes with aspiration; smears prepared immediately
- Air-dried (Diff-Quik/MGG) and alcohol-fixed (Papanicolaou/H&E) stains
Fibroepithelial Neoplasm on FNAC
The term "fibroepithelial neoplasm" on FNAC of an abdominal wall mass encompasses a spectrum of lesions sharing both epithelial and fibrous/stromal components. The three key entities are:
1. Fibroepithelial Polyp (Acrochordon / Skin Tag)
"Fibroepithelial polyps are soft, flesh-colored, bag-like tumors that are often attached to the surrounding skin by a slender stalk. They consist of fibrovascular cores covered by benign squamous epithelium."
- Robbins & Cotran Pathologic Basis of Disease
Clinical features:
- Most common cutaneous lesion; highly prevalent in middle-aged and older individuals
- Found on neck, trunk, face, intertriginous areas - can occur on abdominal skin
- Soft, pendulous, skin-coloured or hyperpigmented
- Attached by a narrow stalk (pedunculated)
- Become more numerous during pregnancy (hormonal stimulation)
- Associated with: diabetes, obesity, intestinal polyposis
Histological / FNAC features:
- Fibrovascular core covered by benign squamous (stratified) epithelium
- No atypia; no mitoses; benign cytomorphology
- Can undergo ischaemic necrosis due to torsion (causes pain)
Associations:
- Sporadic (majority)
- Rare: Birt-Hogg-Dubé syndrome (when combined with perifollicular mesenchyme tumors) - associated with renal neoplasms; genetic counselling needed
Robbins Pathology - benign epidermal/fibroepithelial surface lesions of skin
Management: Simple excision; excellent prognosis; no recurrence
2. Phyllodes Tumor (Classic Biphasic Fibroepithelial Neoplasm)
While classically a breast lesion, phyllodes tumors can rarely arise in ectopic breast tissue on the anterior abdominal wall, or present as metastatic deposits in the abdominal wall.
Definition: A biphasic fibroepithelial neoplasm characterised by leaf-like (phyllodal) epithelial pattern and proliferating stromal component.
Incidence: 0.3-1.0% of all breast/fibroepithelial neoplasms; peak age 35-55 years in women
FNAC Cytological Features of Phyllodes Tumor:
| Feature | Finding |
|---|
| Architecture | Large wavy/folded epithelial clusters in leaf-like arrangement |
| Stromal component | Fibromyxoid stromal clumps - characteristic; reduced epithelial:stromal ratio vs fibroadenoma |
| Epithelial cells | Usually benign cytomorphology; occasionally hyperplastic (enlarged vesicular nuclei, small nucleoli) |
| Stromal cells | Fibroblastic pavements; spindle-shaped |
| Atypia | Increased in higher grades; dispersed atypical stromal cells |
| Malignant features | Multinucleated tumour cells; marked stromal anaplasia; ≥10 mitoses/10 HPF |
Grading (WHO):
| Grade | Stromal Hypercellularity | Atypia | Overgrowth | Border | Mitoses |
|---|
| Benign | Mild | Minimal/None | None | Circumscribed (pushing) | ≤ 4/10 HPF |
| Borderline | Moderate | Moderate | Focal | Focal infiltration | 5-9/10 HPF |
| Malignant | Marked | Marked | Present | Infiltrative (permeative) | ≥ 10/10 HPF |
Key FNAC challenge: Distinguishing fibroadenoma from benign phyllodes tumor is difficult on FNAC alone - the fibromyxoid stromal clumps are the most helpful differentiating feature. Core needle biopsy or excision is often needed for definitive diagnosis.
Management:
- Benign/Borderline: Wide local excision with clear margins (≥ 1 cm)
- Malignant: Wide excision ± mastectomy; axillary dissection NOT routine (lymph node metastasis rare)
- Local recurrence risk present in all grades; follow-up essential
- No role for routine adjuvant chemotherapy/radiation in benign phyllodes
3. Desmoid Tumor (Aggressive Fibromatosis) - The Classic Anterior Abdominal Wall Fibroepithelial/Fibrous Neoplasm
"Desmoid tumors are classically described as an abdominal wall tumor, seen in young women during the postpartum period."
- Mulholland and Greenfield's Surgery, 7th Ed.
Definition: A monoclonal fibroblastic proliferation arising from muscular or aponeurotic structures. Locally aggressive but has no metastatic potential.
Incidence: 2-4 cases per million per year; median age 35 (range 16-79); women > men
Pathogenesis:
- Sporadic cases: Mutations in CTNNB1 (β-catenin gene) - most common
- FAP-associated cases: Germline APC gene mutations; seen in Gardner's syndrome
- Risk factors: pregnancy, prior surgical incision, trauma, hormonal exposure
- 10-15% of FAP patients develop desmoids; after prophylactic colectomy, desmoids become the leading cause of death in FAP
Gross/Microscopic Features:
- Deep-seated in muscles/fascial planes
- Firm, smooth mass with surrounding pseudocapsule
- Microscopically: tumour extends BEYOND the pseudocapsule - fibrous septae extend radially (key feature explaining high local recurrence rates)
- Increased oestrogen receptor-β expression in 80%
Clinical presentation:
- Large (> 5 cm), localised, firm mass with indolent growth
- Minimally painful
- Intra-abdominal: mass effect, intestinal obstruction, mucosal ischaemia
- Notoriously infiltrative - microscopically positive margins in a significant number of resections
FNAC / Biopsy features:
- Bland-looking fibroblastic spindle cells in collagenous stroma
- Low cellularity; no atypia; no mitoses (can be mistaken for benign fibrous tissue)
- Core needle biopsy preferred for diagnosis (FNAC often non-diagnostic due to scant cellularity)
- β-catenin nuclear positivity on immunohistochemistry - key diagnostic marker
Imaging:
- MRI preferred - best defines extent of disease and invasion into adjacent structures
- CT with IV contrast - defines local extent and chest metastases (important if high-grade component suspected)
Schwartz's Surgery - Abdominal wall lipoma specimen; desmoids appear firm, white, and rubbery
Management of Abdominal Wall Desmoid Tumor
Step 1: Active Surveillance (First-line - NCCN recommendation)
- Asymptomatic, non-life-threatening tumors: watchful waiting first
- Periodic MRI scans to monitor
- 29% of desmoids undergo spontaneous regression
- Only 16% require surgery over 3-year follow-up (observational cohort)
Step 2: Medical Therapy (if growing under observation)
| Drug | Mechanism |
|---|
| NSAIDs (Sulindac) | β-catenin pathway modulation |
| Tamoxifen / Anti-oestrogens | Oestrogen receptor-β blockade |
| Imatinib | Tyrosine kinase inhibition (moderate evidence) |
| Sorafenib | TKI - active; approved for desmoid in some guidelines |
| Nirogacestat | γ-secretase inhibitor (newer; approved 2023) |
| Methotrexate + Vinblastine | Cytotoxic; for progressive unresectable disease |
| Doxorubicin (pegylated) | For refractory aggressive cases |
| Radiation (50-54 Gy) | Unresectable tumours or post-op recurrence |
Step 3: Surgery (Selective - not first-line)
- Indicated for: symptomatic disease, risk of invasion of vital structures, enlarging tumors failing other treatment, or women with desmoid considering pregnancy
- Margin-negative resection + immediate mesh reconstruction historically gold standard
- However, local recurrence occurs in up to 1/3 of patients regardless of margin status
- Up to 2/3 of patients with positive margins do NOT recur
- Therefore: function-sparing surgery acceptable even with positive margins on critical structures
FNAC Interpretation Algorithm for Abdominal Wall Mass
FNAC Result: "Fibroepithelial Neoplasm"
|
├── Skin surface/superficial, pedunculated:
│ → Fibroepithelial POLYP (skin tag)
│ → Excision; benign
|
├── Breast tissue / ectopic breast / young woman:
│ → Consider PHYLLODES TUMOR
│ → Core biopsy for grading
│ → Wide excision with clear margins
|
├── Deep mass, muscular/fascial plane, young woman,
│ post-partum, or FAP history:
│ → Consider DESMOID FIBROMATOSIS
│ → MRI + core needle biopsy + β-catenin IHC
│ → Active surveillance first
|
└── Atypical stromal cells, increased mitoses,
infiltrative imaging:
→ Consider MALIGNANT PHYLLODES / SARCOMA
→ Multidisciplinary sarcoma centre referral
Summary Table: Key Fibroepithelial Neoplasms of Abdominal Wall
| Feature | Fibroepithelial Polyp | Phyllodes Tumor | Desmoid Fibromatosis |
|---|
| Origin | Skin/epidermis | Breast fibroepithelial | Muscular/aponeurotic |
| Age/Sex | Middle-aged; both | Women 35-55 | Women; young adults |
| Metastasis | No | Rare (malignant grade only) | Never |
| Local recurrence | No | Yes (all grades) | Yes (up to 30%) |
| FNAC yield | Good | Moderate (core biopsy better) | Low (core biopsy preferred) |
| Key FNAC feature | Benign squamous + fibrovascular core | Fibromyxoid stromal clumps + epithelial clusters | Bland spindle cells, collagenous stroma |
| IHC marker | - | CD34+ stromal cells | β-catenin nuclear+ |
| First-line Rx | Excision | Wide excision (clear margins) | Active surveillance |
| Prognosis | Excellent | Good (benign); variable (malignant) | Good; recurrence possible |
Clinical bottom line: When FNAC of an anterior abdominal wall mass returns "fibroepithelial neoplasm," the most important next step is clinical context + MRI imaging. A pedunculated superficial skin lesion is almost certainly a benign fibroepithelial polyp requiring simple excision. A deep, firm mass in the abdominal musculature in a young postpartum woman with FNAC showing bland spindle cells should prompt core needle biopsy and β-catenin IHC to confirm desmoid fibromatosis, where active surveillance - not immediate surgery - is now the first-line approach.
- Robbins & Cotran Pathologic Basis of Disease (fibroepithelial polyp)
- Schwartz's Principles of Surgery, 11th Ed. (desmoid tumors, abdominal wall)
- Mulholland & Greenfield's Surgery, 7th Ed. (desmoid fibromatosis classification)
- FNAC spectrum data: PMC11131566